Sue Ellison, joint MD of OPM (labels and packaging) Group looks at how counterfeiting measures for pharmaceuticals packaging are being affected in a post-Brexit world.
Counterfeit drugs are big business. The European Union Intellectual Property Office (EUIPO) and the Organisation for Economic Cooperation and Development (OECD) estimate the total value of counterfeit pharmaceuticals traded worldwide to be up to EUR 4.03 billion.